Bristol-Myers Squibb Company (BMY) Next Earnings Date & Options-Implied ±6.8% Move
Bristol-Myers Squibb Company (BMY) receives a Roarable Rating of D+ (Sell) and flashes a Red SELL / AVOID warning (63/100 RQD Confidence). Our SEC filing scanner spotted paper earnings outpacing real operating cash flow (+185.6% (NI vs OCF)) while unpaid customer invoices grew—a classic sign to step aside until cash flow catches up.
Options-Implied Post-Earnings ±6.8% Bell Curve
Will BMY Beat & Rip or Miss Next Quarter?
Trailing EPS: $3.45 • YoY Revenue Growth: -0.2%
Recent SEC Reported Revenue, Net Profit & Diluted EPS Cadence
| Period | Filed | Revenue | Net Profit | Free Cash Flow | Gross Margin |
|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $48.19B | $7.05B | $12.85B | 71.1% |
| FY 2024 | 2024-12-31 | $48.30B | -$8.95B | $13.94B | 71.1% |
| FY 2023 | 2023-12-31 | $45.01B | $8.03B | $11.83B | 44% |
Red-Light Warning Desk: How Pros Profit When Overhyped Stocks Crack (Featuring BMY)
- ✓Live walkthrough of BMY's RQD Radar, SEC cash-conversion gap & downside levels
- ✓3 asymmetric Bear/Hedge setups institutions use when 10-year yields stay elevated
- ✓Includes instant 24/7 email alert whenever any of your stocks flip to Red
BMY Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. -0.2% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on BMY today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for BMY. Explore sector supply chains on /butterfly.
BMY Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhen is BMY's next earnings date?
Based on SEC filing cadence, Bristol-Myers Squibb Company (BMY)'s next quarterly earnings window is estimated around Dec 30, 2026.
How much is BMY stock expected to move on earnings?
Options markets currently imply a ±6.8% post-earnings move for BMY, projecting a trading range between $57.22 and $65.56.